{
  "nct_id": "20190341",
  "age": "Adults",
  "cancer_center_accrual_goal_upper": 0,
  "data_table4": "Interventional",
  "drug_list": {
    "drug": [
      {
        "drug_name": "Sotorasib"
      },
      {
        "drug_name": "Platinum Doublet"
      },
      {
        "drug_name": "Pembrolizumab"
      }
    ]
  },
  "long_title": "A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non–Small Cell Lung Cancers, Negative for PD-L1, and Positive for KRAS p.G12C (CodeBreaK 202)",
  "management_group_list": {
    "management_group": [
      {
        "is_primary": "Y",
        "management_group_name": "HKUMed"
      }
    ]
  },
  "oncology_group_list": {
    "oncology_group": [
      {
        "group_name": "Group 1",
        "is_primary": "N"
      }
    ]
  },
  "phase": "3",
  "principal_investigator": "Dr. Victor LEE",
  "principal_investigator_institution": "HKU",
  "program_area_list": {
    "program_area": [
      {
        "is_primary": "Y",
        "program_area_name": "Program 1"
      }
    ]
  },
  "protocol_id": null,
  "protocol_no": "",
  "protocol_target_accrual": 0,
  "protocol_type": "",
  "prior_treatment_requirements": [
    "Histologically/Cytologically confirmed Stage IV or IIIB or IIIC nonsquamous NSCLC",
    "No history of systemic anticancer therapy in metastatic/non-curable settings",
    "Tumour is negative for PD-L1 expression, and positive for KRAS p.G12C mutation",
    "No molecular alterations for which targeted therapy is approved (including but not limited to EGFR or ALK alteration) other than KRAS p.G12C"
  ],
  "short_title": "Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination in Subjects With Non–Small Cell Lung Cancers",
  "site_list": {
    "site": []
  },
  "sponsor_list": {
    "sponsor": []
  },
  "staff_list": {
    "protocol_staff": []
  },
  "status": "open to accrual",
  "summary": "",
  "treatment_list": {
    "step": [
      {
        "arm": [
          {
            "arm_code": "Arm A",
            "arm_internal_id": 1111,
            "arm_description": "Treatment with Sotorasib + Platinum Doublet",
            "arm_suspended": "N"
          },
          {
            "arm_code": "Arm B",
            "arm_internal_id": 2222,
            "arm_description": "Pembrolizumab + Platinum Doublet",
            "arm_suspended": "N"
          }
        ],
        "step_code": "1",
        "step_type": "Registration",
        "step_internal_id": 1111,
        "match": [
          {
            "and": [
              {
                "clinical": {
                  "oncotree_primary_diagnosis": "Non-Small Cell Lung Cancer"
                }
              },
              {
                "and": [
                  {
                    "genomic": {
                      "hugo_symbol": "!CD274",
                      "variant_category": "Mutation"
                    }
                  },
                  {
                    "genomic": {
                      "hugo_symbol": "KRAS",
                      "variant_category": "Mutation",
                      "protein_change": "p.G12C"
                    }
                  },
                  {
                    "genomic": {
                      "hugo_symbol": "!EGFR",
                      "variant_category": "Mutation"
                    }
                  },
                  {
                    "genomic": {
                      "hugo_symbol": "!ALK",
                      "variant_category": "Mutation"
                    }
                  }
                ]
              }
            ]
          }
        ]
      }
    ]
  }
}